Zydus lifesciences announced that it would launch Vaxiflu-4, India’s first four-angle influenza vaccine, during the southern hemisphere of 2025. The quarter vaccine covering both influenza A and influenza B straps provides a wider protection and significantly reduces the vaccine mismatch.

The vaccine has cleaned the central laboratory (CDL), the company added. Vaxiflu-4 is marketed with Zydus Maxicare, a group of prevention groups. Ahmedabad has developed a rectangular influenza vaccine developed at a vaccine technology center (VTC), which has been shown to be the properties of safe and effective vaccines research, development and manufacture.

Influenza is a contagious respiratory disease caused by influenza viruses that spread from one person to another, mainly through air drops, created by coughing and sneezing or through direct contact with the infected surface or individual.

It causes diseases that vary in seriousness and can sometimes lead to hospitalization or even death, especially in high -risk groups, such as less than five children, and people with immunosuppressive and chronic diseases.

Dr. Sharvil Patel, MD, Zydus lifesciences, said that forecasts are the key to public health in both development and advanced worlds and vaccines can improve the quality of life. In India, urgent access to affordable, high -quality vaccines that can respond to healthcare challenges.

Vaccines, such as Vaxiflu-4, serve the cause of public health through annual immunization and preventing the flu. Zydus lifesciences is a discovery-driven, global life sciences company that finds, develops, manufactures and markets a wide range of health care treatments.

The company stated that the net profit for the consolidated is 29.62 RS SEK 1,023.5 out of four FY25 in SEK 789.6 in RS FY24. Business turnover increased by 16.96 years by 5,269.1 in a quarter of a quarter. Zydus lifesciences’. Shares spread to 0.27 RS 880.20 BSE.

Source

https://www.business-standard.com/markets/capital-market-news/zydus-life-launches-vaccine-for-new-strain-of-influenza-virus-125022700296_1.html

https://www.angelone.in/news/zydus-lifesciences-launches-indias-first-quadrivalent-flu-vaccine